buthionine sulfoximine has been researched along with Huntington Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, DS; Buzescu, R; Chopra, R; Ferrante, RJ; Fox, JH; Hersch, SM; Kazantsev, A; Norflus, F; Singh, B; Swindell, MK; Zucker, B | 1 |
1 other study(ies) available for buthionine sulfoximine and Huntington Disease
Article | Year |
---|---|
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Topics: Animals; Antioxidants; Brain; Buthionine Sulfoximine; Cystamine; Cysteine; Cytoprotection; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Gene Expression Regulation; Glutathione; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptides; Rats | 2004 |